Similar Articles

  • Primary aldosteronism: new approaches to diagnosis and management

    Donald G. Vidt, MD, Alan Bakst, PharmD and Emmanuel L. Bravo, MD
    • Cleveland Clinic Journal of Medicine September 1993, 60 (5) 379-386;

    • Uncertainties persist regarding optimal screening methods, the diagnostic process, diagnostic criteria, and differentiation of the growing number of etiological subgroups.

  • Our evolving understanding of primary aldosteronism

    Ali Mehdi, MD, MEd, FACP, Pratibha Rao, MD, MPH and George Thomas, MD
    • Cleveland Clinic Journal of Medicine April 2021, 88 (4) 221-227;
    • DOI: https://doi.org/10.3949/ccjm.88a.20166

    • Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.

  • Primary pulmonary hypertension in adults

    Bhagwan D. Gupta, M.D, Douglas S. Moodie, M.D and James R. Hodgman, M.D
    • Cleveland Clinic Journal of Medicine December 1980, 47 (4) 275-284;

  • What's new in the treatment of hypertension

    Ray W. Gifford Jr., MD
    • Cleveland Clinic Journal of Medicine March 1997, 64 (3) 143-150;

    • Systolic pressure predicts risk more accurately than diastolic pressure. The current goal of 140/90 is probably not aggressive enough.

  • TOC Icon

    Should primary care physicians screen for depression?

    George E. Tesar, MD
    • Cleveland Clinic Journal of Medicine June 2003, 70 (6) 488-490;

    • Yes, if they have the time and resources to do something about it if they find it.

  • Primary pulmonary hypertension: An overview of epidemiology and pathogenesis

    Ziad W. Ghamra, MD and Raed A. Dweik, MD
    • Cleveland Clinic Journal of Medicine April 2003, 70 (4 suppl 1) S2-S8;

  • Primary aldosteronism: Interpreting the 2025 Endocrine Society clinical practice guideline update

    CME Image
    Nandhini Bindukumari Sureshkumar, MD, Marguerite O. Linz, MD, Pratibha PR Rao, MD, MPH and Ricardo Correa, MD, EdD
    • Cleveland Clinic Journal of Medicine September 2026, 93 (9) 515-522;
    • DOI: https://doi.org/10.3949/ccjm.93a.25107

    • The new guideline agrees with growing evidence that primary aldosteronism is common, often missed, and treatable.

  • Surgeon-Initiated Preoperative Screening: A New Approach

    Christina Johnson, RN, PA-C and Edward J. denBraven, CRNA
    • Cleveland Clinic Journal of Medicine February 2009, 76 (2 esuppl 1) eS40;

  • What’s new in prostate cancer screening and prevention?

    Eric A. Klein, MD
    • Cleveland Clinic Journal of Medicine August 2009, 76 (8) 439-445;
    • DOI: https://doi.org/10.3949/ccjm.76a.02009

    • Two large trials of screening with prostate-specific antigen measurements came to seemingly opposite conclusions. Furthermore, a large trial of selenium and vitamin E found that neither has value in preventing prostate cancer.

  • HIV screening for all: The new standard of care

    Wendy S. Armstrong, MD and Alan J. Taege, MD
    • Cleveland Clinic Journal of Medicine April 2007, 74 (4) 297-301;

    • The US Centers for Disease Control and Prevention now recommends testing all patients age 13 to 64 years in all health care settings, using an “opt-out” rather than an “opt-in” approach. We urge physicians and health care systems to embrace these recommendations.

Previous
Next